Related Experiment Video
Updated: May 22, 2025

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis
Published on: August 11, 2008
Evaluation of five colorimetric methods for rapid detection of multidrug-resistant Mycobacterium tuberculosis
1Akdeniz University Faculty of Health Sciences Research Laboratory, Tuberculosis Research Unit, Antalya, Türkiye; Akdeniz University Institute of Health Sciences, Department of Medical Biotechnology, Antalya, Türkiye.
Aims:
Tuberculosis (TB) continues to pose a major threat to global public health, particularly due to the increasing prevalence of antimicrobial resistance. This study aimed to evaluate the performance of five different colorimetric drug susceptibility testing (DST) methods, including a newly developed assay.
Methods:
A total of 56 clinical Mycobacterium tuberculosis strains with varying resistance profiles, along with two ATCC reference strains, were tested against four first-line anti-TB antibiotics: isoniazid (INH), rifampicin (RIF), streptomycin (STR), and ethambutol (EMB). The assays NRTA, CRTA, CVDTA, MGDTA, and a newly developed disk-based resazurin tube assay (DBRTA) were performed in Middlebrook 7H9 broth at standard critical drug concentrations. Results were compared against the BACTEC MGIT 960 system as the reference method.
Results:
The DST results were obtained within 7 to 14 days. The overall agreement with the reference method was 96.87 % for NRTA, 95.08 % for CRTA, 93.75 % for both CVDTA and MGDTA, and 95.53 % for DBRTA.
Conclusions:
Colorimetric assays, especially DBRTA, offer cost-effective, rapid, and scalable solutions for MDR-TB detection. Their simplicity and affordability make them particularly suitable for routine use in resource-limited settings, contributing to improved TB management and global control efforts.
More Related Videos
09:57System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis
Published on: April 5, 2017
12:39Antimicrobial Susceptibility Testing of Mycobacterium Tuberculosis Complex for First and Second Line Drugs by Broth Dilution in a Microtiter Plate Format
Published on: June 24, 2011